Digestive Support for GLP-1 Treatments: GLP-1 agonists frequently cause digestive side effects, with nausea occurring in 40% of cases, vomiting in 25%, and bowel disturbances in 23%, often leading to treatment discontinuation (Sun F et al., Diabetes Technology & Therapeutics , 2015)
Anyone with hormonal conditions or pineal gland issues should specifically consult with a qualified practitioner, as the pineal gland is hormonally active and plays important regulatory roles
Improved Fat Metabolism: Tirzepatide helps the body break down stored fat more efficiently, leading to greater fat loss, especially around the abdomen
Delayed gastric emptying can present as bloating, early fullness, nausea, and reflux, and about 10% of users reported indigestion while on semaglutide